South Korea’s SolGent has secured an order to supply a US government agency with an additional 7,500 kits which can each perform 100 coronavirus tests, the CEO of the biotech firm told Reuters.
That will double the number of tests US authorities can perform using kits sourced from South Korea to 1.5 million.
SolGent has already sent kits for 150,000 tests while South Korean peers Osang HealthCare and SD BIOSENSOR are due to ship kits capable of performing 600,000 tests today, company sources told Reuters.
Read more here.




























